Novartis Asks Again For Injunction Ahead Of MS Patent Trial
Lawyers for pharma giant Novartis urged a U.K. appeals court on Wednesday to reverse a decision not to block Teva and other generic-drug makers from entering the market for a multiple...To view the full article, register now.
Already a subscriber? Click here to view full article